Hq Han

Title: Hq Han: Innovator in Muscle and Bone Health

Introduction

Hq Han is a prominent inventor based in Thousand Oaks, CA, known for his significant contributions to the fields of muscle and bone health. With a total of 11 patents to his name, Han has developed innovative solutions aimed at treating muscle wasting and bone diseases.

Latest Patents

Among his latest patents are methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteins. These patents describe hybrid soluble ActRIIB-ECD polypeptides that retain binding affinity for myostatin and activin A while demonstrating reduced binding to BMPs, particularly BMP-9. The compositions can be utilized to prepare hybrid ActRIIB ligand trap proteins, which modulate the growth of various tissues, including muscle, bone, cartilage, and blood. These next-generation myostatin/activin inhibitors are considered safer and more effective than existing options, making them valuable for a range of clinical applications.

Career Highlights

Hq Han has worked with notable companies such as Amgen Inc. and Biogen MA Inc., where he has contributed to groundbreaking research and development in his field. His work has had a significant impact on the understanding and treatment of muscle and bone-related conditions.

Collaborations

Throughout his career, Han has collaborated with esteemed colleagues, including Xiaolan Zhou and Thomas Charles Boone, further enhancing the scope and impact of his research.

Conclusion

Hq Han's innovative work in developing hybrid ActRIIB ligand trap proteins showcases his commitment to advancing medical science in muscle and bone health. His contributions continue to pave the way for safer and more effective treatments in the healthcare industry.